Press Releases
Advanced cell-line development: increase productivity and improve antibody-dependent cellular cytotoxicity with transposase technology
Enhancing productivity and antibody-dependent cellular cytotoxicity (ADCC) activity is key to developing high-performing antibody therapeutics. With the right approach and technology, there’s no need to compromise.
Our S-CHOice® and S-AfuCHO™ platforms are designed to optimize cell line performance, ensuring robust productivity while maintaining strong effector function.
Enhancing productivity and antibody-dependent cellular cytotoxicity (ADCC) activity is key to developing high-performing antibody therapeutics. With the right approach and technology, there’s no need to compromise.
Our S-CHOice® and S-AfuCHO™ platforms are designed to optimize cell line performance, ensuring robust productivity while maintaining strong effector function.